Jhaveri Kartik S, Sadaf Arifa
Expert Rev Anticancer Ther. 2009 Apr;9(4):469-81. doi: 10.1586/era.09.13.
Total mesorectal excision has been established as a standard surgical procedure for rectal cancer. MRI is now routinely used for preoperative staging of rectal cancer and provides accurate assessment of the tumor relative to the circumferential margin, that is, the mesorectal fascia. This identifies patients at risk of local recurrence and those likely to benefit from neoadjuvant therapy. Compared with CT and ultrasound, MRI is more reliable for the evaluation of the extent of locoregional disease, planning radiation therapy, assessing postoperative changes and pelvic recurrence. The evaluation of nodal metastases remains a challenge with routine MRI. In this review, we describe the role of MRI in staging rectal cancer as well as highlight some limitations and recent advances to overcome these.
全直肠系膜切除术已成为直肠癌的标准外科手术。目前,MRI常用于直肠癌的术前分期,可准确评估肿瘤相对于环周切缘,即直肠系膜筋膜的情况。这有助于识别有局部复发风险的患者以及可能从新辅助治疗中获益的患者。与CT和超声相比,MRI在评估局部区域疾病范围、规划放射治疗、评估术后变化及盆腔复发方面更可靠。常规MRI对淋巴结转移的评估仍是一项挑战。在本综述中,我们描述了MRI在直肠癌分期中的作用,并强调了一些局限性以及克服这些局限性的最新进展。